Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Neurotoxicology. 2012 Jul 13;33(5):1188–1202. doi: 10.1016/j.neuro.2012.06.013

Figure 9.

Figure 9

Group mean ± S.E. levels (ng/mg/protein) of frontal cortex, nucleus accumbens and striatal DA, DOPAC, HVA and DA turnover (DA TO), NE and 5-HT and 5-HIAA at the completion of behavioral testing for the treatment groups, as indicated from the maternal and lifetime Pb and PS conditions. Group sample sizes as described in Figure 1 and 2, respectively Pb=main effect of Pb; S=main effect of PS; Pb x S=interaction of Pb with PS in the two factor ANOVA.